Cargando…
Providing meaningful survival benefit to hepatocellular carcinoma patients: combination therapy of future
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577984/ https://www.ncbi.nlm.nih.gov/pubmed/36268238 http://dx.doi.org/10.21037/hbsn-22-322 |
| _version_ | 1784811879103725568 |
|---|---|
| author | Sarkar, Devanand |
| author_facet | Sarkar, Devanand |
| author_sort | Sarkar, Devanand |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9577984 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95779842022-10-19 Providing meaningful survival benefit to hepatocellular carcinoma patients: combination therapy of future Sarkar, Devanand Hepatobiliary Surg Nutr Commentary AME Publishing Company 2022-10 /pmc/articles/PMC9577984/ /pubmed/36268238 http://dx.doi.org/10.21037/hbsn-22-322 Text en 2022 Hepatobiliary Surgery and Nutrition. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Commentary Sarkar, Devanand Providing meaningful survival benefit to hepatocellular carcinoma patients: combination therapy of future |
| title | Providing meaningful survival benefit to hepatocellular carcinoma patients: combination therapy of future |
| title_full | Providing meaningful survival benefit to hepatocellular carcinoma patients: combination therapy of future |
| title_fullStr | Providing meaningful survival benefit to hepatocellular carcinoma patients: combination therapy of future |
| title_full_unstemmed | Providing meaningful survival benefit to hepatocellular carcinoma patients: combination therapy of future |
| title_short | Providing meaningful survival benefit to hepatocellular carcinoma patients: combination therapy of future |
| title_sort | providing meaningful survival benefit to hepatocellular carcinoma patients: combination therapy of future |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577984/ https://www.ncbi.nlm.nih.gov/pubmed/36268238 http://dx.doi.org/10.21037/hbsn-22-322 |
| work_keys_str_mv | AT sarkardevanand providingmeaningfulsurvivalbenefittohepatocellularcarcinomapatientscombinationtherapyoffuture |